Trial Identifier: | D6580C00008 |
Sponsor: | AstraZeneca |
Collaborator: |
Parexel International
|
NCTID:: | NCT04232345 |
Start Date: | January 2020 |
Primary Completion Date: | March 2021 |
Study Completion Date: | March 2021 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English version | |
Japanese (US) Translation | |
Simplified Chinese (US) Translation |
Country | Location |
---|---|
United States of America, CA | Glendale, CA, United States of America, 91206 |